GB Sciences, Inc. (GBLX)
OTCMKTS: GBLX · Delayed Price · USD
0.0099
+0.0034 (52.31%)
Jul 3, 2024, 12:48 PM EDT - Market closed
GB Sciences Market Cap
GB Sciences has a market cap or net worth of $4.02 million as of July 3, 2024. Its market cap has decreased by -19.02% in one year.
Market Cap
4.02M
Enterprise Value
5.51M
1-Year Change
-19.02%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since July 5, 2019, GB Sciences's market cap has decreased from $30.51M to $4.02M, a decrease of -86.82%. That is a compound annual growth rate of -33.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2024 | 3.23M | 17.91% |
| Dec 29, 2023 | 2.74M | -58.98% |
| Dec 30, 2022 | 6.67M | 4.98% |
| Dec 31, 2021 | 6.35M | -46.10% |
| Dec 31, 2020 | 11.79M | 12.02% |
| Dec 31, 2019 | 10.52M | -65.51% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 853.15B |
| Novo Nordisk | 626.57B |
| UnitedHealth Group | 456.35B |
| Johnson & Johnson | 351.90B |
| Merck & Co. | 322.67B |
| AbbVie | 295.69B |
| AstraZeneca | 237.45B |
| Novartis AG | 207.98B |